AMRI

Albany Molecular Research, Inc. Press Releases

$16.24
*  
0.02
0.12%
Get AMRI Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading AMRI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMRI Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AMRI to Announce Fourth Quarter and Full Year Results
1/29/2015 8:00:00 AM - PR Newswire


AMRI Receives NIH Contract Award for the Formulation Development and Manufacture of Pre-Clinical and Clinical Drug Product
1/19/2015 8:00:00 AM - PR Newswire
▼-4.47 % Price Change since this news event. The Volume Ratio is 0.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AMRI Announces Agreement with Genovi Pharmaceuticals Limited for Development and Manufacturing of Parenteral Drug Products
1/12/2015 8:35:00 AM - PR Newswire
▼-0.67 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AMRI Announces CFO Transition
1/12/2015 8:30:00 AM - PR Newswire
▼-0.67 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aptuit to Divest Two Non-Core Sites; Facilitates Reinvestment and Accelerated Growth in Core Area of Integrated Solutions
1/9/2015 7:33:00 AM - PR Newswire
▲3.44 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses
1/9/2015 7:00:00 AM - PR Newswire
▲3.44 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


INVESTOR ALERT: The Wagner Firm Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Albany Molecular Research Inc.
1/7/2015 5:24:00 PM - Business Wire
▲1.50 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AMRI to Present at the 33rd Annual J.P. Morgan Healthcare Conference
12/23/2014 8:00:00 AM - PR Newswire
▲5.32 % Price Change since this news event. The Volume Ratio is 0.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber
12/12/2014 9:00:00 AM - PR Newswire


Lifshitz & Miller Law Firm Announces Investigation of Actuate Corporation, Albany Molecular Research Inc., Conn's, Inc., Cubist Pharmaceuticals, Inc., Hawaiian Electric Industries, Inc., and Heritage Financial Group, Inc.
12/11/2014 12:45:00 PM - PR Newswire
▲0.19 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Law Offices of Marc S. Henzel Announces Securities Class Action Periods
12/8/2014 9:11:00 AM - PR Newswire


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Albany Molecular Research, Inc. (AMRI) To Contact The Firm
11/26/2014 4:44:00 PM - PR Newswire


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Albany Molecular Research, Inc. (AMRI) to Contact the Firm
11/19/2014 4:40:00 PM - Market Wire


AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational
11/19/2014 11:15:00 AM - PR Newswire


Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Albany Molecular Research Inc.
11/14/2014 9:30:00 PM - PR Newswire


Harwood Feffer LLP Announces Investigation of Albany Molecular Research Inc.
11/14/2014 8:30:00 PM - PR Newswire


Class Action Lawsuit on Behalf of Albany Molecular Research Inc. Investors Announced by Kirby McInerney LLP
11/14/2014 2:55:00 PM - Business Wire
▲1.06 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Albany Molecular Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
11/14/2014 11:08:00 AM - Business Wire
▲0.25 % Price Change since this news event. The Volume Ratio is 0.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AMRI Announces Third Quarter 2014 Results
11/5/2014 7:30:00 AM - PR Newswire
▼-28.36 % Price Change since this news event. The Volume Ratio is 14.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day